𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents

✍ Scribed by Dao Thi Kim Oanh; Hoang Van Hai; Sang Ho Park; Hyun-Jung Kim; Byung-Woo Han; Hyung-Sook Kim; Jin-Tae Hong; Sang-Bae Han; Van Thi My Hue; Nguyen-Hai Nam

Book ID
113496043
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
377 KB
Volume
21
Category
Article
ISSN
0960-894X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Antitumor effects of a novel sulfur-cont
Antitumor effects of a novel sulfur-containing hydroxamate histone deacetylase inhibitor H40
✍ Juan Long; Jinyan Zhao; Zheng Yan; Ziliang Liu; Nan Wang πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 468 KB

## Abstract Histone deacetylase (HDAC) inhibitors are among the most promising targeted anticancer agents and are potent inducers of growth arrest, differentiation, and/or apoptotic cell death of transformed cells. In this study, antitumor effects of a novel sulfur‐containing hydroxamate HDAC inhib

Dietary agents as histone deacetylase in
Dietary agents as histone deacetylase inhibitors
✍ Melinda C. Myzak; Emily Ho; Roderick H. Dashwood πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

## Abstract In cancer cells, an imbalance often exists between histone acetyltransferase (HAT) and histone deacetylase (HDAC) activities, and various drug companies are actively seeking competitive HDAC inhibitors for chemotherapeutic intervention. Cancer cells appear to be more sensitive than nont